High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanoma

BACKGROUND It remains unclear whether high doses of glucocorticoids have a negative impact on the efficacy of checkpoint inhibitors. To control for the potential association between immune‐related adverse events (irAEs) and improved survival, this study examined a unique cohort of patients who had t...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Cancer Ročník 124; číslo 18; s. 3706 - 3714
Hlavní autori:	Faje, Alexander T., Lawrence, Donald, Flaherty, Keith, Freedman, Christine, Fadden, Riley, Rubin, Krista, Cohen, Justine, Sullivan, Ryan J.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Wiley Subscription Services, Inc 15.09.2018
Predmet:	checkpoint inhibitors Electronic health records Electronic medical records Glucocorticoids Health care hypophysitis Immune checkpoint Immunotherapy Inhibitors ipilimumab Melanoma Monoclonal antibodies Oncology Patients Survival melanoma hypophysitis glucocorticoids checkpoint inhibitors ipilimumab
ISSN:	0008-543X, 1097-0142, 1097-0142
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!